Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hexalacton in Type 1 Diabetes with Microalbuminuria
NCT00843388Phase 4Unknown
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Mar 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of spironolactone in diabetic nephropathy (DN) (2 arms), sponsored by Steno Diabetes Center Copenhagen. Primary endpoint: Albuminuria at 60 days. Status: unknown.
02
Drugs
spironolactone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00843388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843388.